Literature DB >> 16175631

Effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses.

Henry H L Chan1.   

Abstract

BACKGROUND AND OBJECTIVES: The use of lasers, light sources, and radiofrequency devices in Asian patients differs from their use in Caucasians in several respects. STUDY DESIGN/
MATERIALS AND METHODS: The disease spectrum is very different with pigmentary disorders being more commonly encountered in Asian populations. Asian skin, with its higher epidermal melanin content, is more likely to develop adverse reactions, especially post-inflammatory hyperpigmentation (PIH), following treatment. RESULTS AND
CONCLUSIONS: The purpose of this article is to discuss the effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16175631     DOI: 10.1002/lsm.20244

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  4 in total

1.  Clinical evaluation of the efficacy and safety of combined bipolar radiofrequency and optical energies vs. optical energy alone for the treatment of aging hands.

Authors:  Ines Verner; Tuvia Dror Kutscher
Journal:  Lasers Med Sci       Date:  2017-06-23       Impact factor: 3.161

2.  Objective assessment of intensive targeted treatment for solar lentigines using intense pulsed light with wavelengths between 500 and 635 nm.

Authors:  Yohei Tanaka; Yuichiro Tsunemi; Makoto Kawashima
Journal:  Lasers Surg Med       Date:  2015-10-14       Impact factor: 4.025

3.  Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report.

Authors:  Georgia Siow Kiang Lee
Journal:  J Cosmet Laser Ther       Date:  2008-12       Impact factor: 2.247

Review 4.  Acquired hyperpigmentations.

Authors:  Tania Ferreira Cestari; Lia Pinheiro Dantas; Juliana Catucci Boza
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.